SCHEMBL25486953

SCHEMBL25486953

COC(=O)c1cc(C)c(-c2ccc(F)cn2)cc1NC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.46
▸ TYK2 P29597 1/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ SLC6A4 P31645 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ DHODH Q02127 1/20 0.38
▸ ABL1 P00519 2/20 0.37
▸ GABRA5 P31644 1/20 0.37
▸ DYRK1A Q13627 2/20 0.36
▸ TGFBR1 P36897 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ TGFBR2 P37173 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24525459 0.87 JAK2 (0.43) JAK2TYK2SMN1; SMN2NPC1RAB9A
SCHEMBL29654495 0.85 JAK2 (0.44) JAK2TYK2SMN1; SMN2NPC1RAB9A
SCHEMBL24525378 0.85 JAK2 (0.44) JAK2TYK2SMN1; SMN2NPC1RAB9A
SCHEMBL25486984 0.85 DHODH (0.37) TYK2SMN1; SMN2NPC1RAB9ADHODH
SCHEMBL24525012 0.82 NPC1 (0.43) JAK2TYK2SMN1; SMN2NPC1RAB9A
SCHEMBL25485749 0.82 SLC6A4 (0.52) SMN1; SMN2NPC1RAB9ACASP3SENP8
SCHEMBL25484858 0.80 ALPL (0.43) SMN1; SMN2NPC1RAB9ASLC6A4SLC6A3
SCHEMBL24525182 0.75 DHODH (0.36) TYK2SMN1; SMN2NPC1RAB9ADHODH
SCHEMBL24525000 0.73 CFTR (0.37) DHODHABL1TGFBR1KDM4EMAPT
SCHEMBL29654506 0.73 CFTR (0.37) DHODHABL1TGFBR1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159563-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159563-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES KRAS, NRAS, HRAS JAK2 822/4885TYK2 2648/4885SMN1; SMN2 3697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback